Hematopoietic stem cells (Nexell)

N/A

Report date: 2023/01/12 15:52:18

Base Information

Drug NameHematopoietic stem cells (Nexell)
Drug Alias Namehematopoietic stem cells (CGD)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsGranulomatous Disease, ChronicNeutropenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNexell Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNexell Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsGranulomatous Disease, ChronicNeutropenia

Other Information

ATC CodeN/A
Related LinksN/A